M. Engelbrecht

发表

Evaluation of Six Diffusion-weighted MRI Models for Assessing Effects of Neoadjuvant Chemoradiation in Pancreatic Cancer Patients.

J. Stoker, A. Nederveen, A. Bel, 2018, International journal of radiation oncology, biology, physics.

Comparison of six fit algorithms for the intra-voxel incoherent motion model of diffusion-weighted magnetic resonance imaging data of pancreatic cancer patients

Martijn Froeling, Arjan Bel, Sebastiano Barbieri, 2018, PloS one.

Pathological validation and prognostic potential of quantitative MRI in the characterization of pancreas cancer: preliminary experience

M. J. van de Vijver, J. Stoker, A. Nederveen, 2020, Molecular oncology.

Detection of clinically significant prostate cancer in biopsy‐naïve men: direct comparison of systematic biopsy, multiparametric MRI‐ and contrast‐ultrasound‐dispersion imaging‐targeted biopsy

C. D. Savci-Heijink, T. D. de Reijke, M. Mischi, 2020, BJU international.

CHAPTER 8 Best fits for DWI How best to fit diffusion-weighted magnetic resonance imaging data of pancreatic cancer patients

J. Stoker, M. Froeling, O. Gurney-Champion, 2017 .

Irreversible electroporation for the treatment of localized prostate cancer: a summary of imaging findings and treatment feedback.

D. D. de Bruin, T. D. de Reijke, J. J. de la Rosette, 2017, Diagnostic and interventional radiology.

The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol

D. D. de Bruin, T. D. de Reijke, J. J. de la Rosette, 2014, BMJ Open.

Interobserver Variability in CT-based Morphologic Tumor Response Assessment of Colorectal Liver Metastases.

C. Dejong, G. Kazemier, J. V. van Waesberghe, 2022, Radiology. Imaging cancer.

Repeatability and correlations of dynamic contrast enhanced and T2* MRI in patients with advanced pancreatic ductal adenocarcinoma.

J. Stoker, A. Nederveen, M. Besselink, 2018, Magnetic resonance imaging.

Pseudoprogression on bevacizumab treatment: tumor-dynamics in the modern era of systemic treatment for metastatic colorectal cancer

C. Punt, T. V. van Gulik, J. Huiskens, 2017, Acta oncologica.

Added value of 3T MRI and the MRI-halo sign in assessing resectability of locally advanced pancreatic cancer following induction chemotherapy (IMAGE-MRI): prospective pilot study

J. Stoker, A. Nederveen, H. V. van Laarhoven, 2022, Langenbeck's Archives of Surgery.

Retrospective evaluation of national MRI reporting quality for lateral lymph nodes in rectal cancer patients and concordance with prospective re-evaluation following additional training

E. D. Geijsen, E. Verdaasdonk, J. Plate, 2022, Insights into Imaging.

The Prognostic Value of Total Tumor Volume Response Compared With RECIST1.1 in Patients With Initially Unresectable Colorectal Liver Metastases Undergoing Systemic Treatment

C. Dejong, G. Kazemier, J. V. van Waesberghe, 2021, Annals of surgery open : perspectives of surgical history, education, and clinical approaches.

The role of tumour biological factors in technical anatomical resectability assessment of colorectal liver metastases following induction systemic treatment: An analysis of the Dutch CAIRO5 trial.

C. Dejong, G. Kazemier, C. Punt, 2023, European journal of cancer.

Outcomes of Resectability Assessment of the Dutch Colorectal Cancer Group Liver Metastases Expert Panel.

G. Kazemier, C. Punt, J. D. de Wilt, 2019, Journal of the American College of Surgeons.

Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy.

C. D. Savci-Heijink, T. D. de Reijke, M. Roobol, 2018, European urology oncology.

The added value of systematic biopsy in men with suspicion of prostate cancer undergoing multiparametric MRI-targeted biopsy.

T. D. de Reijke, M. Gayet, H. Beerlage, 2019, Urologic oncology.

The prostate cancer detection rates of CEUS-targeted versus MRI-targeted versus systematic TRUS-guided biopsies in biopsy-naïve men: a prospective, comparative clinical trial using the same patients

M. Mischi, H. Wijkstra, C. K. Mannaerts, 2017, BMC Urology.

The efficacy and safety of irreversible electroporation for the ablation of renal masses: a prospective, human, in-vivo study protocol

Hessel Wijkstra, Ton G van Leeuwen, Daniel M de Bruin, 2015, BMC Cancer.

Addition of MRI for CT-based pancreatic tumor delineation: a feasibility study

M. V. van Herk, J. Stoker, C. Rasch, 2017, Acta oncologica.

LBA21 FOLFOX/FOLFIRI plus either bevacizumab or panitumumab in patients with initially unresectable colorectal liver metastases (CRLM) and left-sided and RAS/BRAFV600E wild-type tumour: Phase III CAIRO5 study of the Dutch Colorectal Cancer Group

G. Kazemier, J. D. de Groot, M. Hendriks, 2022, Annals of Oncology.

Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases, a study protocol of the randomised phase 3 CAIRO5 study of the Dutch Colorectal Cancer Group (DCCG)

G. Kazemier, G. Meijer, C. Punt, 2015, BMC Cancer.

Prostate cancer staging using imaging

M. van der Graaf, A. Heerschap, J. Barentsz, 2000, BJU international.

Combined quantitative dynamic contrast‐enhanced MR imaging and 1H MR spectroscopic imaging of human prostate cancer

Mark Rijpkema, Arend Heerschap, Marinette van der Graaf, 2004, Journal of magnetic resonance imaging : JMRI.

Prostate cancer localization by novel magnetic resonance dispersion imaging

Massimo Mischi, Hessel Wijkstra, Tamerlan A. Saidov, 2013, 2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).

Intersurgeon Variability in Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases: Analysis of the Liver Expert Panel of the Dutch Colorectal Cancer Group

C. Dejong, G. Kazemier, C. Punt, 2023, Annals of Surgical Oncology.

Reliable Visualization of the Treatment Effect of Transperineal Focal Laser Ablation in Prostate Cancer Patients by Magnetic Resonance Imaging and Contrast-enhanced Ultrasound Imaging

D. D. de Bruin, T. D. de Reijke, H. Beerlage, 2023, European urology open science.

Revisiting the Potential of Alternating Repetition Time Balanced Steady-State Free Precession Imaging of the Abdomen at 3 T

J. Stoker, A. Nederveen, A. Bel, 2016, Investigative radiology.

MRI and contrast-enhanced ultrasound imaging for evaluation of focal irreversible electroporation treatment: results from a phase I-II study in patients undergoing IRE followed by radical prostatectomy

C. D. Savci-Heijink, D. D. de Bruin, T. D. de Reijke, 2015, European Radiology.

Evaluation of National Surgical Practice for Lateral Lymph Nodes in Rectal Cancer in an Untrained Setting

E. D. Geijsen, E. Verdaasdonk, L. Kroese, 2023, Annals of Surgical Oncology.

Irreversible electroporation for the treatment of localized prostate cancer: a summary of imaging findings and treatment feedback.

D. D. de Bruin, T. D. de Reijke, H. Wijkstra, 2017, Diagnostic and interventional radiology.

First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group.

G. Kazemier, C. Punt, G. Patijn, 2023, The Lancet. Oncology.

Deep learning models for automatic tumor segmentation and total tumor volume assessment in patients with colorectal liver metastases

G. Patijn, F. Vadakkumpadan, S. van Dieren, 2023, European Radiology Experimental.

Evaluation of Six Diffusion-weighted MRI Models for Assessing Effects of Neoadjuvant Chemoradiation in Pancreatic Cancer Patients.

A. Nederveen, A. Bel, M. Besselink, 2018, International journal of radiation oncology, biology, physics.

Addition of MRI for CT-based pancreatic tumor delineation: a feasibility study

M. V. van Herk, C. Rasch, A. Nederveen, 2017, Acta oncologica.

Prognostic value of total tumor volume in patients with colorectal liver metastases: A secondary analysis of the randomized CAIRO5 trial with external cohort validation.

G. Patijn, J. Huiskens, R. Swijnenburg, 2024, European journal of cancer.